Kaufman Bros.
View Older Stories View More Recent Stories
-
Kaufman Bros. Cuts Price Target on Clearwire (CLWR) But Still Calls for Over 60% Upside
-
Kaufman Bros. Cuts Price Target on MetroPCS (PCS) as Net Adds and EBITDA Both Miss Expectations
-
Kaufman Bros. Starts Syntel, Inc. (SYNT) at Hold; Proven Execution Track Record with Marquee Clients
-
Kaufman Bros. Reinstates Coverage on Genpact Ltd. (G) at Buy; Leadership Position in Offshore BPO
-
Kaufman Bros. Maintains a 'Buy' on TriQuint Semiconductor; Apple 4S Not Enough to Revive TQNT
-
Kaufman Bros. Maintains a 'Hold' on Equinix (EQIX); Solid Quarter; Capital Spending for 2012 Going Up Again
-
Kaufman Bros. Cuts Price Target on Broadcom (BRCM), Management Sees Slowing All Around
-
Notable Analyst Rating Changes 10/26: (AMTD) (NFLX) (REGN) Upgraded; (HGSI) (FSLR) (MF) Downgraded
-
Kaufman Bros. Downgrades First Solar (FSLR) to Hold; Stock Appears Cheap, but Uncertainty Now Warrants Caution
-
Q3 Preview: Sprint (S) Quarter May Be Non-Event; Funding Plan, iPhone Will Be Investor Focus
-
Kaufman Bros. Reiterates a 'Buy' on Texas Instruments (TXN); Getting Hit Like All Analog Semis - Lowering GAAP Estimates
-
Kaufman Bros. Maintains a 'Buy' on Acme Packet (APKT); Reports Q3 Results; Reaffirms Guidance; Still No Word on THE BIG Contract
-
Kaufman Bros. Downgrades Aixtron (AIXG) to Hold; Reducing Estimates and Price Target to Reflect Demand
-
Kaufman Bros. Reiterates an 'Buy' on Veeco Instruments (VECO); At Some Point, Valuation Matters
-
Q3 Preview: AT&T (T) Wades Through Difficult Economy, T-Mobile Deal Remains an Overhang
-
Kaufman Cuts Price Target on Cree (CREE), No Near-Term Upside or Catalysts
-
Intel (INTC) overall volatility at 33; shares at three-year highs on Q3 results
-
Q3 Preview: Intel (INTC) May Already Have Priced In Downside Ahead of Results
-
Kaufman Bros. Reiterates a 'Buy' on TriQuint Semiconductor (TQNT); Raising Estimates on Increasing Apple (AAPL) Expectations
-
Kaufman Cuts Price Target on VanceInfo Technologies (VIT), Could Top Low Expectations
-
Kaufman Bros. Cuts Price Target on Johnson Controls (JCI), Calls Shares Oversold
-
Kaufman Cuts Price Target on ADTRAN (ADTN) Following Q3 Results & Q4 Guidance
-
Adtran (ADTN) volatility elevated into Q3 results and guidance
-
Notable Analyst Rating Changes 10/10: (NFLX) (SGY) (POT) Upgraded; (S) (SFSF) (LUV) Downgraded
-
Sprint (S) Shares Continue Lower; Downgraded Five Times Following Meeting Disaster
-
Kaufman Bros. Downgrades Sprint (S) to Hold; Newest Strategy Misses the Mark, Puts Balance Sheet at Risk
-
Kaufman Cuts Price Target on Acme Packet (APKT) Following New Outlook
-
Kaufman Bros. Maintains a 'Buy' on Sprint (S); Investors Seek the Path to Higher Margins
-
Kaufman Cuts Price Target on Acuity Brands (AYI) Ahead of Q4 Earnings
-
Kaufman Cuts Price Target on Veeco Instruments (VECO) Following Slowing Demand in 2H11
-
Kaufman Cuts Price Target on Aixtron (AIXG), Remains Bullish Long-Term
-
Kaufman Bros. Maintains a 'Buy' on Clearwire (CLWR); Having Conversations with Apparently Everyone
-
Kaufman Cuts Price Target on TriQuint Semiconductor ( TQNT), Sees New Outlook Already Priced In
-
Notable Analyst Rating Changes 09/22: (NFLX) (INTC) (YHOO) Upgraded; (JNJ) (ZMH) (PG) Downgraded
-
Kaufman Bros Starts NuVasive (NUVA) at Hold, Royalties Continue to Weigh on Margins
-
Kaufman Bros. Starts Cyberonics (CYBX) at Hold, Sets Price Target at $28
-
Kaufman Bros. Starts St. Jude Medical (STJ) at Buy, Strong Pipeline & Strong Growth
-
Kaufman Bros. Starts Stryker (SYK) at Buy, Continues to See Growth
-
Kaufman Bros. Starts Zimmer Holdings (ZMH) at Hold; Full Exposure to Weak Ortho Market
-
Kaufman Bros. Starts Varian Medical (VAR) at Buy; Innovation, Services & New Technologies Soften Lingering Capex Market Weakness
-
Kaufman Bros. Starts Hologic (HOLX) at Buy; Positive Leverage to 3D Mammography, a New Technology Cycle Offsetting Weak Capex Markets
-
Kaufman Bros. Starts Conceptus (CPTS) at Hold; Balancing Sales & Marketing Programs Needed to Drive Growth as Patients Continue to Hide
-
Kaufman Bros. Starts Boston Scientific (BSX) at Hold; Progress Made, But Remains a Turnaround, with Tough Growth Outlook
-
Kaufman Bros. Starts Alphatec Holdings (ATEC) at Hold; Looking for Sustained Execution in a More Challenging Spine Market
-
Kaufman Bros. Starts AtriCure Inc. (ATRC) at Buy; Upside From Persistent AF Label for Synergy Ablation System
-
Kaufman Bros. Upgrades SunPower (SPWRA) to Hold; Fairly Valued After Recent Decline
-
Kaufman Bros. Cuts Price Target on ADTRAN (ADTN), Sees Strong Q3 Results
-
Kaufman Bros. Maintains a 'Buy' on Clearwire (CLWR); China Mobile (CHL) Agrees to Collaborate on TD-LTE
-
Kaufman Bros. Cuts Price Target on TriQuint Semiconductor (TQNT), Maintains Long-Term Outlook